Genetics
Dr. Sarah Ahmed
CRISPR Screening in Rare Disease Discovery
Functional genomics is accelerating how researchers investigate rare disease mechanisms.
Dr. Sarah AhmedApr 20, 2026
8 min read
610 views
Abstract
CRISPR screening helps map disease pathways and uncover therapeutic hypotheses.
1. Introduction
Rare disease investigation often lacks large datasets, making functional evidence especially valuable.
2. Screening Strategy
Loss-of-function and activation screens can identify modifier genes and validate targets.
3. Translational Relevance
Functional discoveries become more actionable when they connect directly to measurable phenotypes.
- Target prioritization
- Mechanism validation
- Therapeutic hypothesis generation
4. Future Directions
Patient-derived models may make CRISPR findings more clinically transferable.
5. Conclusion
CRISPR screening bridges genetic clues and therapeutic direction.
References
- CRISPR reference 1
- CRISPR reference 2
- CRISPR reference 3
Tags:CRISPRRare DiseaseFunctional Genomics
Share:
Discussion (0)
Join the conversationNo discussions yet. Be the first to share your thoughts!